- Home
- BHM vs ATRA Comparison
BHM vs ATRA Comparison
Compare BHM & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHM | ATRA |
|---|---|---|
| Founded | 2022 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9M | 37.6M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | BHM | ATRA |
|---|---|---|
| Price | $9.48 | $4.59 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $15.00 | $6.00 |
| AVG Volume (30 Days) | 7.3K | ★ 429.8K |
| Earning Date | 01-01-0001 | 03-06-2026 |
| Dividend Yield | ★ 5.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.97 |
| Revenue | $74,462,000.00 | ★ $151,930,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.46 |
| Revenue Growth | 27.95 | ★ 51.27 |
| 52 Week Low | $8.05 | $4.20 |
| 52 Week High | $14.81 | $19.15 |
Technical Indicators
Market Signals| Indicator | BHM | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 50.90 | 29.41 |
| Support Level | $8.60 | $4.50 |
| Resistance Level | $9.40 | $5.11 |
| Average True Range (ATR) | 0.43 | 0.38 |
| MACD | 0.01 | 0.34 |
| Stochastic Oscillator | 74.77 | 6.61 |
Price Performance
Historical ComparisonAbout BHM Bluerock Homes Trust Inc.
Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The Company is an externally managed REIT managed and advised by Bluerock Homes Manager, LLC.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).